Clinical Trial Update: Improving Colorectal Cancer Early Screening in Portugal: Identification of Gut Microbiome Biomarkers in Stool (GUTBIOME-PT)

View source ↗

Summary

This clinical trial in Portugal aims to identify gut microbiome biomarkers in stool to improve early screening for colorectal cancer. The study (GUTBIOME-PT) is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Gulbenkian Institute for Molecular Medicine | Conditions: Colorectal Cancer Screening, Colorectal Cancer (CRC) | Status: RECRUITING